ResearcherFujian Medical UniversityActive in the last 2 years
Huixing Chen
Matched on OpenAlex author ID A5018713323. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2017: 1 paper · 2018: none · 2019: 2 papers · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper
Papers 5
- Comprehensive analysis of the expression and prognostic value of ARMCs in pancreatic adenocarcinoma. Last author DOI 10.1186/s12885-024-13365-5↗
- Sulindac (K-80003) with nab-paclitaxel and gemcitabine overcomes drug-resistant pancreatic cancer. Co-author DOI 10.1186/s12943-024-02128-2↗
- Silencing of long noncoding RNA LINC00958 prevents tumor initiation of pancreatic cancer by acting as a sponge of microRNA-330-5p to down-regulate PAX8. Co-author DOI 10.1016/j.canlet.2018.12.017↗
- RER1 enhances carcinogenesis and stemness of pancreatic cancer under hypoxic environment. Co-author DOI 10.1186/s13046-018-0986-x↗
- The over expression of long non-coding RNA ANRIL promotes epithelial-mesenchymal transition by activating the ATM-E2F1 signaling pathway in pancreatic cancer: … Co-author DOI 10.1016/j.ijbiomac.2017.03.123↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Shi Chen · 4 shared papers, 2017–2025 · strength 0.57
- Paper Comprehensive analysis of the expression and prognostic value of ARMCs in pancreatic adenocarcinoma. DOI 10.1186/s12885-024-13365-5↗
- Paper Sulindac (K-80003) with nab-paclitaxel and gemcitabine overcomes drug-resistant pancreatic cancer. DOI 10.1186/s12943-024-02128-2↗
- Paper RER1 enhances carcinogenesis and stemness of pancreatic cancer under hypoxic environment. DOI 10.1186/s13046-018-0986-x↗
- Zuwei Wang · 2 shared papers, 2024–2025 · strength 0.41
- Yanling Chen · 3 shared papers, 2017–2025 · strength 0.39
- Paper Comprehensive analysis of the expression and prognostic value of ARMCs in pancreatic adenocarcinoma. DOI 10.1186/s12885-024-13365-5↗
- Paper Silencing of long noncoding RNA LINC00958 prevents tumor initiation of pancreatic cancer by acting as a sponge of micro… DOI 10.1016/j.canlet.2018.12.017↗
- Paper The over expression of long non-coding RNA ANRIL promotes epithelial-mesenchymal transition by activating the ATM-E2F1 … DOI 10.1016/j.ijbiomac.2017.03.123↗
- Yifeng Tian · 3 shared papers, 2017–2019 · strength 0.25
- Paper Silencing of long noncoding RNA LINC00958 prevents tumor initiation of pancreatic cancer by acting as a sponge of micro… DOI 10.1016/j.canlet.2018.12.017↗
- Paper RER1 enhances carcinogenesis and stemness of pancreatic cancer under hypoxic environment. DOI 10.1186/s13046-018-0986-x↗
- Paper The over expression of long non-coding RNA ANRIL promotes epithelial-mesenchymal transition by activating the ATM-E2F1 … DOI 10.1016/j.ijbiomac.2017.03.123↗
- Chenghong Peng · 3 shared papers, 2017–2019 · strength 0.25
- Paper Silencing of long noncoding RNA LINC00958 prevents tumor initiation of pancreatic cancer by acting as a sponge of micro… DOI 10.1016/j.canlet.2018.12.017↗
- Paper RER1 enhances carcinogenesis and stemness of pancreatic cancer under hypoxic environment. DOI 10.1186/s13046-018-0986-x↗
- Paper The over expression of long non-coding RNA ANRIL promotes epithelial-mesenchymal transition by activating the ATM-E2F1 … DOI 10.1016/j.ijbiomac.2017.03.123↗
- Guanxiang Zhuo · 1 shared paper, 2025 · strength 0.23
- Baiyong Shen · 2 shared papers, 2019 · strength 0.18
- Cheng‐Yu Liao · 1 shared paper, 2024 · strength 0.18
- Hong-Yi Lin · 1 shared paper, 2024 · strength 0.18
- Chengke Xie · 1 shared paper, 2024 · strength 0.18
- Yongding Wu · 1 shared paper, 2024 · strength 0.18
- Yao-Dong Wang · 2 shared papers, 2017–2019 · strength 0.16
- Paper Silencing of long noncoding RNA LINC00958 prevents tumor initiation of pancreatic cancer by acting as a sponge of micro… DOI 10.1016/j.canlet.2018.12.017↗
- Paper The over expression of long non-coding RNA ANRIL promotes epithelial-mesenchymal transition by activating the ATM-E2F1 … DOI 10.1016/j.ijbiomac.2017.03.123↗
- Jiangzhi Chen · 1 shared paper, 2019 · strength 0.09
- Long Huang · 1 shared paper, 2019 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.